Health care stocks fell Thursday afternoon with the NYSE Health Care Index down 0.5% and the Health Care Select Sector SPDR Fund (XLV) shedding 0.6%.
The iShares Biotechnology ETF (IBB) dropped 1.1%.
In sector news, Mallinckrodt and Endo are set to merge in a deal valued at $6.7 billion in cash and stock with the drug makers set to list shares of the new firm on the New York Stock Exchange.
In corporate news, Lifeward (LFWD) shares jumped 18%. The US Food and Drug Administration cleared ReWalk 7, the newest version of the company's personal exoskeleton device.
ImmunoPrecise Antibodies (IPA) shares rose 11% after the company announced a partnership with an undisclosed biotech firm to discover and develop antibody-drug conjugates and bispecific antibodies to treat cancer.
Dogwood Therapeutics (DWTX) shares tumbled 27% after the company launched a registered direct offering priced at $8.26 a share.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.